The oligonucleotides market is expected to reach a size of usd 16.10 billion by 2035. Related markets, including microRNA and aptamers, are also projected to experience significant growth, with the microRNA market potentially reaching usd 11.37 billion and the aptamers market surpassing usd 26.23 billion by the same year. The exact relationship between these market sizes is unclear, but all are expected to see substantial expansion.